Technomark Medical Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Investments
  • 11

  • Portfolio
  • 1

  • Exits
  • 6

Exits

Technomark Medical Ventures General Information

Company Description

Technomark Medical Ventures was a London, England based venture capital firm. The firm specialized in early-stage investments. It used to invest in biotechnology and pharmaceutical sectors.

Business Details

Website
www.tmv.eu.com
Year Founded
2008
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Corporate Office
  • 11 Westbourne Grove
  • King House
  • London W2 4UA
  • England, United Kingdom

Technomark Medical Ventures Investments (11)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Secro 22-Sep-2023 Seed Round Business/Productivity Software Generating Revenue
Ranier Technology 25-Sep-2012 Surgical Devices Out of Business
BioVex Group 26-May-2005 Biotechnology Clinical Trials - Phase 3
BioVex Group 03-Oct-2004 Biotechnology Clinical Trials - Phase 3
BioVex Group 03-Oct-2004 Biotechnology Clinical Trials - Phase 3
Paradigm Therapeutics. 09-Dec-2002 Drug Discovery Generating Revenue
Amura Technologies 20-Mar-2002 Biotechnology Generating Revenue
Ranier Technology 01-Feb-2002 Surgical Devices Out of Business
Sirus 11-Sep-2001 Later Stage VC Biotechnology Generating Revenue
Matrix Therapeutics 01-Mar-2001 Early Stage VC Drug Discovery Bankruptcy: Liquidation
You’re viewing 10 of 11 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Technomark Medical Ventures Exits (6)

Company Name Exit Date Exit Type Exit Size
Ranier Technology 21-Oct-2015 Bankruptcy: Admin/Reorg
Matrix Therapeutics 29-May-2012
BioVex Group 04-Mar-2011
Paradigm Therapeutics. 31-Mar-2007
Amura Technologies 06-Jan-2006 Buyout/LBO
Sirus 01-Mar-2004 Merger/Acquisition
To view Technomark Medical Ventures’s complete exits history, request access »

Technomark Medical Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Technomark Medical Ventures Co-Investors (7)

Name With Exits Lead Partner Series Industry
Augment Ventures 1 Series chart Industry bar
Kluz Ventures Series chart Industry bar
Motion Ventures Series chart Industry bar
SeaAhead Series chart Industry bar
TMV (Trail Mix Ventures) Series chart Industry bar
You’re viewing 5 of 7 co-investors. Get the full list »

Technomark Medical Ventures FAQs

  • What is Technomark Medical Ventures?

    Technomark Medical Ventures was a London, England based venture capital firm.

  • When was Technomark Medical Ventures founded?

    Technomark Medical Ventures was founded in 2008.

  • Where is Technomark Medical Ventures headquartered?

    Technomark Medical Ventures is headquartered in London, United Kingdom.

  • How many investments has Technomark Medical Ventures made?

    Technomark Medical Ventures has made 11 investments.

  • What has Technomark Medical Ventures invested in?

    Technomark Medical Ventures has made numerous investments in companies like Secro, Ranier Technology, and BioVex Group within the Business/Productivity Software, Surgical Devices, and Biotechnology industries.

  • What has Technomark Medical Ventures invested in recently?

    Technomark Medical Ventures's latest investment was on 22-Sep-2023 in Secro, a company within the Business/Productivity Software industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process